Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-19T03:23:30.055Z Has data issue: false hasContentIssue false

The relationship between negative symptom subdomains and cognition

Published online by Cambridge University Press:  18 April 2016

J. Lim
Affiliation:
Research Division, Institute of Mental Health, Singapore
S.-A. Lee
Affiliation:
Research Division, Institute of Mental Health, Singapore
M. Lam
Affiliation:
Research Division, Institute of Mental Health, Singapore
A. Rapisarda
Affiliation:
Research Division, Institute of Mental Health, Singapore Neuroscience & Behavioral Disorders, Duke-NUS Graduate Medical School, Singapore
M. Kraus
Affiliation:
Department of Psychiatry & Behavioral Sciences, Duke University Medical Center, Durham, NC, USA
R. S. E. Keefe
Affiliation:
Department of Psychiatry & Behavioral Sciences, Duke University Medical Center, Durham, NC, USA
J. Lee*
Affiliation:
Research Division, Institute of Mental Health, Singapore Department of General Psychiatry 1, Institute of Mental Health, Singapore Office of Clinical Sciences, Duke-NUS Graduate Medical School, Singapore
*
*Address for correspondence: Dr J. Lee, Research Division, Institute of Mental Health, 10 Buangkok View, Singapore 539747, Singapore. (Email: [email protected])

Abstract

Background

Negative symptoms and cognitive deficits in schizophrenia are partially overlapping. However, the nature of the relationship between negative symptoms and cognition remains equivocal. Recent reviews have demonstrated the presence of two negative symptom subdomains, diminished emotional expression (DEE) and avolition. In view of this, we sought to clarify the relationship between negative symptoms and cognitive domains.

Method

A total of 687 participants with schizophrenia were assessed on measures of psychopathology and cognition. Three cognitive factors, namely executive function, fluency/memory and speed/vigilance were computed from the cognitive tests. Confirmatory factor analysis was utilized to examine if a one-factor or two-factor negative model was applicable to our sample. Subsequently, the relationships between negative symptoms and cognition were examined using structural equation modeling.

Results

Results demonstrated that the two-factor model fitted the data well. While negative symptoms were mildly to moderately associated with cognition, we found that DEE had unique associations with cognition compared to social avolition, contributing to the validity of the constructs and suggesting the possibility of common underlying substrates in negative symptoms and cognition.

Conclusions

Our study highlighted the need to classify DEE and social avolition separately as both are necessary in refining the complex relationship between negative symptoms and cognition as well as potentially guiding treatment and management of schizophrenia.

Type
Original Articles
Copyright
Copyright © Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Addington, J (2000). Negative symptoms and the relationship to cognitive functioning. In Cognition in Schizophrenia: Impairments, Importance, and Treatment Strategies (ed Sharma, T. and Harvey, P.D.), pp. 193209. Oxford University Press: Oxford, UK.Google Scholar
Bagney, A, Rodriguez-Jimenez, R, Martinez-Gras, I, Sanchez-Morla, EM, Santos, JL, Jimenez-Arriero, MA, Lobo, A, McGorry, PD, Palomo, T (2013). Negative symptoms and executive function in schizophrenia: does their relationship change with illness duration? Psychopathology 46, 241248.Google Scholar
Bell, MD, Mishara, AL (2006). Does negative symptom change relate to neurocognitive change in schizophrenia? Implications for targeted treatments. Schizophrenia Research 81, 1727.Google Scholar
Benton, AL, Hamsher, K, Varney, NR, Spreen, O (1983). Contributions to Neuropsychological Assessment. Oxford University Press: New York.Google Scholar
Blanchard, JJ, Cohen, AS (2006). The structure of negative symptoms within schizophrenia: implications for assessment. Schizophrenia Bulletin 32, 238245.Google Scholar
Chang, WC, Hui, CLM, Chan, SKW, Lee, EHM, Wong, GHY, Chen, EYH (2014). Relationship between diminished expression and cognitive impairment in first-episode schizophrenia: a prospective three-year follow-up study. Schizophrenia Research 152, 146151.Google Scholar
Cohen, AS, Kim, Y, Najolia, GM (2013). Psychiatric symptom versus neurocognitive correlates of diminished expressivity in schizophrenia and mood disorders. Schizophrenia Research 146, 249253.Google Scholar
Cohen, AS, Morrison, SC, Brown, LA, Minor, KS (2012). Towards a cognitive resource limitations model of diminished expression in schizotypy. Journal of Abnormal Psychology 121, 109118.CrossRefGoogle ScholarPubMed
Cornblatt, BA, Risch, NJ, Faris, G, Friedman, D, Erlenmeyer-Kimling, L (1988). The continuous performance test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry research 26, 223238.CrossRefGoogle ScholarPubMed
Dibben, CRM, Rice, C, Laws, K, McKenna, PJ (2009). Is executive impairment associated with schizophrenic syndromes? A meta-analysis. Psychological Medicine 39, 381392.CrossRefGoogle ScholarPubMed
Dickinson, D, Ramsey, ME, Gold, JM (2007). Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry 64, 532542.Google Scholar
Dominguez, M de G, Viechtbauer, W, Simons, CJP, van Os, J, Krabbendam, L (2009). Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations. Psychological Bulletin 135, 157171.CrossRefGoogle ScholarPubMed
Faerden, A, Vaskinn, A, Finset, A, Agartz, I, Ann Barrett, E, Friis, S, Simonsen, C, Andreassen, OA, Melle, I (2009). Apathy is associated with executive functioning in first episode psychosis. BMC Psychiatry 9, 1.CrossRefGoogle ScholarPubMed
Fervaha, G, Foussias, G, Agid, O, Remington, G (2014 a). Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia. Acta Psychiatrica Scandinavica 130, 290299.CrossRefGoogle Scholar
Fervaha, G, Zakzanis, KK, Foussias, G, Graff-Guerrero, A, Agid, O, Remington, G (2014 b). Motivational deficits and cognitive test performance in schizophrenia. JAMA Psychiatry 71, 10581065.Google Scholar
First, MB, Williams, JB, Karg, RS, Spitzer, RL (2015). Structured Clinical Interview for DSM-5 Disorders, Research Version (SCID-5-RV). American Psychiatric Publishing: New York.Google Scholar
Foussias, G, Agid, O, Fervaha, G, Remington, G (2014). Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders. European Neuropsychopharmacology 24, 693709.Google Scholar
Foussias, G, Remington, G (2010). Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophrenia Bulletin 36, 359369.Google Scholar
Fusar-Poli, P, Borgwardt, S, Bechdolf, A, Addington, J, Riecher-Rössler, A, Schultze-Lutter, F, Keshavan, M, Wood, S, Ruhrmann, S, Seidman, LJ, Valmaggia, L, Cannon, T, Velthorst, E, De Haan, L, Cornblatt, B, Bonoldi, I, Birchwood, M, McGlashan, T, Carpenter, W, McGorry, P, Klosterkötter, J, McGuire, P, Yung, A (2013). The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 70, 107120.Google Scholar
Gold, S, Arndt, S, Nopoulos, P, O'Leary, DS, Andreasen, NC (1999). Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. American Journal of Psychiatry 156, 13421348.Google Scholar
Gruber, O, Chadha Santuccione, A, Aach, H (2014). Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system. Frontiers in Psychiatry 5, 32.CrossRefGoogle ScholarPubMed
Hartmann-Riemer, MN, Hager, OM, Kirschner, M, Bischof, M, Kluge, A, Seifritz, E, Kaiser, S (2015). The association of neurocognitive impairment with diminished expression and apathy in schizophrenia. Schizophrenia Research 169, 427432.Google Scholar
Harvey, PD, Koren, D, Reichenberg, A, Bowie, CR (2006). Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophrenia Bulletin 32, 250258.CrossRefGoogle ScholarPubMed
Heaton, RK, Chelune, GJ, Talley, JL, Kay, GG, Curtiss, G (1993). Wisconsin Card Sort Test Manual: Revised and Expanded. Psychological Assessment Resources: Odessa, FL.Google Scholar
Horan, WP, Kring, AM, Gur, RE, Reise, SP, Blanchard, JJ (2011). Development and psychometric validation of the clinical assessment interview for negative symptoms (CAINS). Schizophrenia Research 132, 140145.Google Scholar
Jiang, J, Sim, K, Lee, J (2013). Validated five-factor model of positive and negative syndrome scale for schizophrenia in Chinese population. Schizophrenia Research 143, 3843.Google Scholar
Kay, SR, Fiszbein, A, Opler, LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261276.Google Scholar
Keefe, RSE, Bilder, RM, Harvey, PD, Davis, SM, Palmer, BW, Gold, JM, Meltzer, HY, Green, MF, Miller, DD, Canive, JM, Adler, LW, Manschreck, TC, Swartz, M, Rosenheck, R, Perkins, DO, Walker, TM, Stroup, TS, McEvoy, JP, Lieberman, JA (2006). Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 31, 20332046.Google Scholar
Keefe, RSE, Goldberg, TE, Harvey, PD, Gold, JM, Poe, MP, Coughenour, L (2004). The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophrenia Research 68, 283297.Google Scholar
Keefe, RSE, Harvey, PD, Lenzenweger, MF, Davidson, M, Apter, SH, Schmeidler, J, Mohs, RC, Davis, KL (1992). Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatry Research 44, 153165.Google Scholar
Kimhy, D, Yale, S, Goetz, RR, McFarr, LM, Malaspina, D (2006). The factorial structure of the schedule for the deficit syndrome in schizophrenia. Schizophrenia Bulletin 32, 274278.CrossRefGoogle ScholarPubMed
Kirkpatrick, B, Fenton, WS, Carpenter, WT, Marder, SR (2006). The NIMH-MATRICS consensus statement on negative symptoms. Schizophrenia Bulletin 32, 214219.CrossRefGoogle ScholarPubMed
Kirkpatrick, B, Strauss, GP, Nguyen, L, Fischer, BA, Daniel, DG, Cienfuegos, A, Marder, SR (2011). The brief negative symptom scale: psychometric properties. Schizophrenia Bulletin 37, 300305.Google Scholar
Konstantakopoulos, G, Ploumpidis, D, Oulis, P, Patrikelis, P, Soumani, A, Papadimitriou, GN, Politis, AM (2011). Apathy, cognitive deficits and functional impairment in schizophrenia. Schizophrenia Research 133, 193198.Google Scholar
Kring, AM, Gur, RE, Blanchard, JJ, Horan, WP, Reise, SP (2013). The clinical assessment interview for negative symptoms (CAINS): final development and validation. American Journal of Psychiatry 170, 165172.Google Scholar
Lam, M, Collinson, SL, Eng, GK, Rapisarda, A, Kraus, M, Lee, J, Chong, SA, Keefe, RSE (2014). Refining the latent structure of neuropsychological performance in schizophrenia. Psychological Medicine 44, 3557-3570.Google Scholar
Levkovitz, Y, Mendlovich, S, Riwkes, S, Braw, Y, Levkovitch-Verbin, H, Gal, G, Fennig, S, Treves, I, Kron, S (2010). A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. Journal of Clinical Psychiatry 71, 138149.CrossRefGoogle ScholarPubMed
Liemburg, E, Castelein, S, Stewart, R, van der Gaag, M, Aleman, A, Knegtering, H, Genetic Risk and Outcome of Psychosis (GROUP) Investigators (2013). Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts. Journal of Psychiatric Research 47, 718725.Google Scholar
Messinger, JW, Trémeau, F, Antonius, D, Mendelsohn, E, Prudent, V, Stanford, AD, Malaspina, D (2011). Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research. Clinical Psychology Review 31, 161168.Google Scholar
Millan, MJ, Fone, K, Steckler, T, Horan, WP (2014). Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment. European Neuropsychopharmacology 24, 645692.Google Scholar
Mueser, KT, Sayers, SL, Schooler, NR, Mance, RM, Haas, GL (1994). A multisite investigation of the reliability of the scale for the assessment of negative symptoms. American Journal of Psychiatry 151, 14531462.Google ScholarPubMed
Nakaya, M, Ohmori, K (2008). A two-factor structure for the schedule for the deficit syndrome in schizophrenia. Psychiatry Research 158, 256259.Google Scholar
Nieuwenstein, MR, Aleman, A, de Haan, EH (2001). Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin card sorting test. continuous performance test. Journal of Psychiatric Research 35, 119125.Google Scholar
Peralta, V, Cuesta, MJ (1995). Negative symptoms in schizophrenia: a confirmatory factor analysis of competing models. The American Journal of Psychiatry 152, 14501457.Google Scholar
Perlick, DA, Rosenheck, RA, Kaczynski, R, Bingham, S, Collins, J (2008). Association of symptomatology and cognitive deficits to functional capacity in schizophrenia. Schizophrenia Research 99, 192199.Google Scholar
R Core Team (2014). R: A language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria.Google Scholar
Rocca, P, Montemagni, C, Zappia, S, Piterà, R, Sigaudo, M, Bogetto, F (2014). Negative symptoms and everyday functioning in schizophrenia: a cross-sectional study in a real world-setting. Psychiatry Research 218, 284289.Google Scholar
Rosseel, Y (2012). lavaan: an R package for structural equation modeling. Journal of Statistical Software 48, 136.Google Scholar
Roth, RM, Flashman, LA, Saykin, AJ, McAllister, TW, Vidaver, R (2004). Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits. American Journal of Psychiatry 161, 157159.Google Scholar
Sanfilipo, M, Lafargue, T, Rusinek, H, Arena, L, Loneragan, C, Lautin, A, Rotrosen, J, Wolkin, A (2002). Cognitive performance in schizophrenia: relationship to regional brain volumes and psychiatric symptoms. Psychiatry Research 116, 123.CrossRefGoogle ScholarPubMed
Schreiber, JB, Nora, A, Stage, FK, Barlow, EA, King, J (2006). Reporting structural equation modeling and confirmatory factor analysis results: a review. Journal of Educational Research 99, 323337.Google Scholar
Strauss, GP, Hong, LE, Gold, JM, Buchanan, RW, McMahon, RP, Keller, WR, Fischer, BA, Catalano, LT, Culbreth, AJ, Carpenter, WT, Kirkpatrick, B (2012). Factor structure of the brief negative symptom scale. Schizophrenia Research 142, 9698.CrossRefGoogle ScholarPubMed
Strauss, GP, Horan, WP, Kirkpatrick, B, Fischer, BA, Keller, WR, Miski, P, Buchanan, RW, Green, MF, Carpenter, WT (2013). Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. Journal of Psychiatric Research 47, 783790.Google Scholar
Tandon, R, Gaebel, W, Barch, DM, Bustillo, J, Gur, RE, Heckers, S, Malaspina, D, Owen, MJ, Schultz, S, Tsuang, M, Van Os, J, Carpenter, W (2013). Definition and description of schizophrenia in the DSM-5. Schizophrenia Research 150, 310.Google Scholar
Wallwork, RS, Fortgang, R, Hashimoto, R, Weinberger, DR, Dickinson, D (2012). Searching for a consensus five-factor model of the positive and negative syndrome scale for schizophrenia. Schizophrenia Research 137, 246250.Google Scholar
Wechsler, D (1999). Wechsler Abbreviated Scale of Intelligence: WASI. The Psychological Corporation: San Antonio, TX.Google Scholar